Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-22

FDA Approved: TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25% — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

Alembic Pharmaceuticals received FDA approval for timolol maleate ophthalmic gel-forming solution in 0.25% (and 0.5%) strengths via original application for tre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol Maleate Ophthalmic Gel Forming Solution 0.25% (timolol maleate ophthalmic gel forming solution 0.25%)
  • Timolol Maleate Ophthalmic Gel Forming Solution 0.5% (Timolol maleate ophthalmic gel-forming solution)

Snippet

ORIG AP for TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25% (TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25%)